<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/41846/dr-reddy-s-laboratories-ltd/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>A hunt for quality large caps available cheap</title>
			<link>https://www.valueresearchonline.com/stories/47397/a-hunt-for-quality-large-caps-available-cheap/</link>
			<pubDate>Wed, 09 Oct 2019 13:22:11 +0530</pubDate>
			<category>Stock Ideas</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/47397_binocular-01__w320__h240__.jpg&quot; alt=&quot;A hunt for quality large caps available cheap&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Following the recent correction, we went on a search for quality large-cap stocks</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/47397/a-hunt-for-quality-large-caps-available-cheap/</guid>
		</item>
		<item>
			<title>Fall of Pharma</title>
			<link>https://www.valueresearchonline.com/stories/32267/fall-of-pharma/</link>
			<pubDate>Thu, 13 Oct 2016 12:22:16 +0530</pubDate>
			<category>Marketwire</category>
			<description>The pharma sector, which once used to be the star of the Street, has been witnessing bad times></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/32267/fall-of-pharma/</guid>
		</item>
		<item>
			<title>Giants fall too</title>
			<link>https://www.valueresearchonline.com/stories/32041/giants-fall-too/</link>
			<pubDate>Mon, 19 Sep 2016 02:49:20 +0530</pubDate>
			<category>Stockwire</category>
			<description>Belonging to the market index is no guarantee that a stock will continue to beat the market and remain an outperformer></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/32041/giants-fall-too/</guid>
		</item>
		<item>
			<title>Who wins in India: Value or Growth?</title>
			<link>https://www.valueresearchonline.com/stories/31533/who-wins-in-india-value-or-growth/</link>
			<pubDate>Fri, 15 Jul 2016 13:12:10 +0530</pubDate>
			<category>Fundwire</category>
			<description>This comparison pits told old rivals against each other using MSCI India Indices. Time determines the answer></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/31533/who-wins-in-india-value-or-growth/</guid>
		</item>
		<item>
			<title>FIIs Vs DIIs: Different strokes</title>
			<link>https://www.valueresearchonline.com/stories/31127/fiis-vs-diis-different-strokes/</link>
			<pubDate>Fri, 20 May 2016 10:30:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>An analysis of stock market transactions reveals that FIIs and domestic institutions are taking contrasting views on sectors></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/31127/fiis-vs-diis-different-strokes/</guid>
		</item>
		<item>
			<title>Grab top stocks quoting at a discount</title>
			<link>https://www.valueresearchonline.com/stories/30740/grab-top-stocks-quoting-at-a-discount/</link>
			<pubDate>Fri, 01 Apr 2016 16:00:44 +0530</pubDate>
			<category>Stockwire</category>
			<description>The ongoing market downturn has put several companies at a bargain. Here are the top Sensex companies that are quoting at a discount></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/30740/grab-top-stocks-quoting-at-a-discount/</guid>
		</item>
		<item>
			<title>Going strong</title>
			<link>https://www.valueresearchonline.com/stories/29866/going-strong/</link>
			<pubDate>Wed, 06 Jan 2016 11:56:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Even though the USFDA created problems for large pharma companies, their smaller counterparts have been doing very well></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29866/going-strong/</guid>
		</item>
		<item>
			<title>Small is beautiful in pharma</title>
			<link>https://www.valueresearchonline.com/stories/29589/small-is-beautiful-in-pharma/</link>
			<pubDate>Thu, 10 Dec 2015 11:38:29 +0530</pubDate>
			<category>Stockwire</category>
			<description>With high numbers of ANDAs, mid-rung pharma companies could outperform their larger peers in the future></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29589/small-is-beautiful-in-pharma/</guid>
		</item>
		<item>
			<title>The sweet pill</title>
			<link>https://www.valueresearchonline.com/stories/29520/the-sweet-pill/</link>
			<pubDate>Thu, 03 Dec 2015 11:48:12 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Dr Reddy&#039;s Laboratories has proved to be one of the best pharma stocks as far as the growth in its revenues and profitability is concerned></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29520/the-sweet-pill/</guid>
		</item>
		<item>
			<title>The most rewarding stocks of the decade</title>
			<link>https://www.valueresearchonline.com/stories/29480/the-most-rewarding-stocks-of-the-decade/</link>
			<pubDate>Mon, 30 Nov 2015 11:53:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Each of these companies has faced tough periods but each has overcome them. See what the future holds for these multibaggers></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29480/the-most-rewarding-stocks-of-the-decade/</guid>
		</item>
		<item>
			<title>The quest for value</title>
			<link>https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</link>
			<pubDate>Tue, 20 Oct 2015 17:56:55 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/29141_29141__w320__h240__.jpg&quot; alt=&quot;The quest for value&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</guid>
		</item>
		<item>
			<title>Does opportunity buying work?</title>
			<link>https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</link>
			<pubDate>Wed, 24 Jun 2015 12:40:03 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/28229_28229__w320__h240__.jpg&quot; alt=&quot;Does opportunity buying work?&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Buying distressed stocks may not always yield good returns</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</guid>
		</item>
		<item>
			<title>Fighting Fit</title>
			<link>https://www.valueresearchonline.com/stories/27132/fighting-fits/</link>
			<pubDate>Tue, 10 Feb 2015 11:43:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/27132_27132__w320__h240__.jpg&quot; alt=&quot;Fighting Fit&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Robust sales in the US along with recovery in the domestic market drives earnings for the pharma sector</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27132/fighting-fits/</guid>
		</item>
		<item>
			<title>Ballooning Legal Expenses</title>
			<link>https://www.valueresearchonline.com/stories/26954/ballooning-legal-expenses/</link>
			<pubDate>Thu, 15 Jan 2015 13:56:00 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/26954_26954__w320__h240__.jpg&quot; alt=&quot;Ballooning Legal Expenses&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Legal expenses could be a drag on a company&#039;s profitability &amp; could also consume significant productive time. Here are 12 such companies</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/26954/ballooning-legal-expenses/</guid>
		</item>
		<item>
			<title>Patent Challenger</title>
			<link>https://www.valueresearchonline.com/stories/20907/patent-challenger/</link>
			<pubDate>Wed, 12 Sep 2012 11:16:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Dr. Reddy’s has 73 ANDAs pending approval along with 36 Para IVs &amp; 6 FTFs…></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/20907/patent-challenger/</guid>
		</item>
		<item>
			<title>The Biggest Purchases</title>
			<link>https://www.valueresearchonline.com/stories/11676/the-biggest-purchases/</link>
			<pubDate>Fri, 25 Jul 2008 17:01:00 +0530</pubDate>
			<category>Fundwire</category>
			<description>Bharti Airtel was the most bought stock by funds in the past 6 months. Here are the other major purchases></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11676/the-biggest-purchases/</guid>
		</item>
		<item>
			<title>We Appreciate Depreciating Rupee</title>
			<link>https://www.valueresearchonline.com/stories/11649/we-appreciate-depreciating-rupee/</link>
			<pubDate>Mon, 21 Jul 2008 17:16:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>The falling rupee might not be good for the economy, but for the export-oriented sectors it spells good news></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11649/we-appreciate-depreciating-rupee/</guid>
		</item>
		<item>
			<title>The Most Fancied Buys</title>
			<link>https://www.valueresearchonline.com/stories/11612/the-most-fancied-buys/</link>
			<pubDate>Mon, 14 Jul 2008 16:22:00 +0530</pubDate>
			<category>Fundwire</category>
			<description>In June, the equity assets of funds fell by 17%. See what the managers bought to steady themselves></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11612/the-most-fancied-buys/</guid>
		</item>
		<item>
			<title>Stocks in the news </title>
			<link>https://www.valueresearchonline.com/stories/10431/stocks-in-the-news/</link>
			<pubDate>Sat, 15 Sep 2007 14:34:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Here is a brief compilation on stock specific news and other reports and data that had a bearing on the market last week. ></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/10431/stocks-in-the-news/</guid>
		</item>
		<item>
			<title>Zurich India Equity</title>
			<link>https://www.valueresearchonline.com/stories/1407/zurich-india-equity/</link>
			<pubDate>Mon, 29 Oct 2001 13:16:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>For its large-cap, quality stock biases and diversity as well as above average returns, Zurich India Equity is an attractive core holding for a growth portfolio></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1407/zurich-india-equity/</guid>
		</item>
    </channel>
</rss>
